News & Updates
Filter by Specialty:
Marine n-3 PUFAs do not affect incident PAD risk
16 Oct 2021
Higher intake of marine n-3 polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exerts no significant protective effect against incident peripheral artery disease (PAD), a recent study has found.
Marine n-3 PUFAs do not affect incident PAD risk
16 Oct 2021Hydroxychloroquine use does not increase risk of heart failure in RA patients
15 Oct 2021
byStephen Padilla
Use of hydroxychloroquine (HCQ) does not contribute to the development of heart failure (HF) in patients with rheumatoid arthritis (RA), a study has shown.
Hydroxychloroquine use does not increase risk of heart failure in RA patients
15 Oct 2021Methotrexate–leflunomide combo safe in rheumatoid arthritis
15 Oct 2021
Methotrexate (MTX) plus leflunomide (LEF) demonstrates a relatively good safety profile overall compared with the combination of MTX and sulfasalazine (SSZ) and strategies involving advanced therapies in rheumatoid arthritis (RA), reports a study.